Chronic Kidney Diseases, Covid19
Conditions
Keywords
Fear, Quality of life, Anxiety, Depression
Brief summary
In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression, physical activity, fear of movement and quality of life in patients with chronic kidney disease during COVID-19 pandemic. The investigators will evaluate these parameters in patients with chronic kidney disease and compare the findings of healthy individuals during COVID-19 pandemic
Interventions
None listed
Sponsors
Hacettepe University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Having been diagnosed with chronic kidney disease * Being clinically stable * Volunteering to participate in the research
Exclusion criteria
* Having a cognitive problem * Not being literate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fear of COVID-19 | 5 minutes | COVID-19 phobia will be evaluated using Fear of COVID-19 Scale. |
| Physical activity | 5 minutes | Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Qol | 10 minutes | Quality of life will be evaluated using SF-36 |
| Anxiety and depression | 5 minutes | Anxiety and depression will be evaluated using Hospital Anxiety and Depression scale (HADS). |
| Fear of movement | 10 minutes | Fear of movement will be evaluated using the Tampa Scale for Kinesiophobia |
Countries
Turkey (Türkiye)
Outcome results
None listed